Personalizing Adjuvant Endocrine Therapy for Early-Stage Hormone Receptor–Positive Breast Cancer
Author:
Affiliation:
1. Department of Cancer Medicine, Gustave Roussy, Villejuif, France
2. BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada
3. The University of Chicago, Chicago, IL
Abstract
Publisher
American Society of Clinical Oncology (ASCO)
Subject
General Medicine
Link
https://ascopubs.org/doi/pdfdirect/10.1200/EDBK_350358
Reference75 articles.
1. Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
2. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
3. Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials
4. St. Gallen/Vienna 2015: A Brief Summary of the Consensus Discussion
5. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Canine Breast Carcinomas: Recent Advances in Diagnostic and Treatment Strategies;Advanced Therapeutics;2024-08-16
2. Androgen receptor: Structure, signaling, function and potential drug discovery biomarker in different breast cancer subtypes;Life Sciences;2024-07
3. Exploring novel protein-based biomarkers for advancing breast cancer diagnosis: A review;Clinical Biochemistry;2024-07
4. Breast cancer survivors’ opinion on personalizing endocrine therapy and developing informative tools;npj Breast Cancer;2024-06-17
5. Ribociclib plus Endocrine Therapy in Early Breast Cancer;New England Journal of Medicine;2024-03-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3